info@pdci.ca
Newsletter Sign-Up
Login to PDCI Services
Contact Us
Navigation
Home
About Us
What We Do
Develop Effective P&R Strategies
Establish Optimal Pricing
Demonstrate Value
Achieve Timely Market Access
Our Team
Careers
Services
Case Studies
News & Events
Resources
Provincial & CDR Deadlines
Common Drug Review (CDR) Submission Deadlines and CDEC Meeting Dates
PMPRB
PMPRB CPI Adjustment Factors Allowable Price Increases
PMPRB HDAP Meeting Dates & Submission Deadlines
Links
Consultation Responses
Blog
Publications
What’s New
Home
What’s New
05
Sep
2023
pCPA Appoints Douglas Clark as its First CEO
September 5, 2023
On September 5, 2023, the pan-Canadian Pharmaceutical Alliance (pCPA) announced the appointment of Douglas Clark as its first ...
Read More
03
Aug
2023
PCPA Seeks Stakeholder Input On Its Proposed Process To Implement CADTH Time-Limited Recommendations
August 3, 2023
The pan-Canadian Pharmaceutical Alliance (pCPA) introduced its proposed pCPA Temporary Access Process (pTAP) and invited stakeholders’ input on ...
Read More
11
Jul
2023
Updates on PMPRB Activities in June 2023 NEWSletter
July 11, 2023
On June 6, 2023, the Patented Medicine Prices Review Board (PMPRB) released its first NEWSletter of 2023, providing ...
Read More
11
Jul
2023
CADTH Announces Changes to Reimbursement Reviews Process & Fee Schedule Update
July 11, 2023
On June 5, 2023, the Canadian Agency for Drugs and Technologies in Health (CADTH) announced a series of ...
Read More
Previous
1
2
3
4
5
6
7
...
96
Next